CN113573780B - 针对耐药性细菌或炎症诱导性细菌的抗菌组合物 - Google Patents

针对耐药性细菌或炎症诱导性细菌的抗菌组合物 Download PDF

Info

Publication number
CN113573780B
CN113573780B CN202080013258.9A CN202080013258A CN113573780B CN 113573780 B CN113573780 B CN 113573780B CN 202080013258 A CN202080013258 A CN 202080013258A CN 113573780 B CN113573780 B CN 113573780B
Authority
CN
China
Prior art keywords
bacteria
base sequence
intestinal
drug
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080013258.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN113573780A (zh
Inventor
本田贤也
安间惠子
新幸二
成岛圣子
古市宗弘
河口贵昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keio University
Original Assignee
Keio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keio University filed Critical Keio University
Publication of CN113573780A publication Critical patent/CN113573780A/zh
Application granted granted Critical
Publication of CN113573780B publication Critical patent/CN113573780B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202080013258.9A 2019-03-07 2020-03-05 针对耐药性细菌或炎症诱导性细菌的抗菌组合物 Active CN113573780B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962815101P 2019-03-07 2019-03-07
US62/815,101 2019-03-07
PCT/JP2020/009423 WO2020179868A1 (ja) 2019-03-07 2020-03-05 薬剤耐性細菌又は炎症惹起性細菌に対する抗菌組成物

Publications (2)

Publication Number Publication Date
CN113573780A CN113573780A (zh) 2021-10-29
CN113573780B true CN113573780B (zh) 2025-05-06

Family

ID=72338206

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080013258.9A Active CN113573780B (zh) 2019-03-07 2020-03-05 针对耐药性细菌或炎症诱导性细菌的抗菌组合物

Country Status (8)

Country Link
US (2) US20220125858A1 (enExample)
EP (1) EP3957367A4 (enExample)
JP (1) JP7488581B2 (enExample)
CN (1) CN113573780B (enExample)
AU (1) AU2020232066B2 (enExample)
CA (1) CA3125323A1 (enExample)
TW (1) TWI843817B (enExample)
WO (1) WO2020179868A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024185738A1 (enExample) * 2023-03-07 2024-09-12
CN118146998B (zh) * 2024-03-14 2024-08-27 广东悦创生物科技有限公司 一株长双歧杆菌长亚种ks1及其在制备抗衰老和助睡眠药品中的应用
CN119842563B (zh) * 2025-03-17 2025-06-06 昆明医科大学第一附属医院(云南省皮肤病医院) 多尔氏菌emf18-06b1d及其用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019017389A1 (ja) * 2017-07-18 2019-01-24 学校法人慶應義塾 Ｔｈ１細胞誘導性細菌に対する抗菌組成物
WO2019118515A2 (en) * 2017-12-11 2019-06-20 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
JP5300772B2 (ja) * 2010-03-26 2013-09-25 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
RU2567009C2 (ru) * 2010-12-17 2015-10-27 Компани Жервэ Данон ШТАММ Lactococcus lactis ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ РАССТРОЙСТВА ПИЩЕВАРЕНИЯ И ЕГО ПРИМЕНЕНИЕ
EP3546566A4 (en) 2016-11-01 2020-05-27 Keio University TH1 CELL INDUCING BACTERIA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019017389A1 (ja) * 2017-07-18 2019-01-24 学校法人慶應義塾 Ｔｈ１細胞誘導性細菌に対する抗菌組成物
WO2019118515A2 (en) * 2017-12-11 2019-06-20 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms

Also Published As

Publication number Publication date
US20250249049A1 (en) 2025-08-07
CA3125323A1 (en) 2020-09-10
US20220125858A1 (en) 2022-04-28
EP3957367A4 (en) 2023-03-22
JPWO2020179868A1 (enExample) 2020-09-10
WO2020179868A1 (ja) 2020-09-10
TW202100172A (zh) 2021-01-01
EP3957367A1 (en) 2022-02-23
TWI843817B (zh) 2024-06-01
JP7488581B2 (ja) 2024-05-22
AU2020232066B2 (en) 2025-05-08
CN113573780A (zh) 2021-10-29
AU2020232066A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
US20230263843A1 (en) Microbiota composition, as a marker of responsiveness to anti-pd1/pd-l1/pd-l2 antibodies and use of microbial modulators for improving the efficacy of an anti-pd1/pd-l1/pd-l2 ab-based treatment
AU2016361583B2 (en) Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization
JP2023015099A (ja) 制御性ｔ細胞の増殖または集積を誘導するヒト由来細菌
US12036249B2 (en) Anti-bacterial composition against TH1 cell-inducing bacteria
US20250249049A1 (en) Antibacterial composition against drug-resistant bacteria or pro-inflammatory bacteria
JP7399400B2 (ja) Ｐａｒａｐｒｅｖｏｔｅｌｌａ属に属する細菌を有効成分として含有する、トリプシン活性を抑制するための組成物
US12285475B2 (en) Bacterium capable of inducing TH1 cells
US20230263839A1 (en) Composition for inhibiting trypsin activity containing as active ingredient bacterium belonging to genus paraprevotella
US11364269B2 (en) Methods and compositions for reducing Listeria monocytogenes infection or colonization
WO2021221110A1 (ja) Ｔｈ１細胞及び／又はＴｈ１７細胞の増殖又は活性化を誘導する小腸内細菌
HK40018045A (en) Anti-bacterial composition against th1 cell-inducing bacteria

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant